Notably, a Business Group on Health survey fielded earlier this year found that 87% of employers expect the availability of oral medications to increase demand for GLP-1s, while only 9% predict a price drop
Jens Juul Holst, MD, DMSc, is professor of Medical Physiology in the Department of Biomedical Sciences at the Faculty of Health Sciences, University of Copenhagen, where he is also the vice-chairman
Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects
Therefore, the development of novel drug delivery systemswhether by enhancing BRB penetration or through direct ocular targeting (e.g., long-acting intravitreal formulations)is a critical and rate-limiting step for the clinical translation of these agents
Those with severe gastrointestinal conditions may require alternative treatments
4.2 Modifiable risk factors Obesity and BMI: Pre-transplant obesity is a well-established risk factor (83, 84)